AI in Clinical Trials Market Size
AI in Clinical Trials Market Size, Share, Growth & Trend Analysis Report by 2024 - 2030
The Global AI in Clinical Trials Market size was valued at USD 1.5 Bn in 2023 and is expected to reach USD 4.11 Bn by 2030, at a CAGR of 15.5 %.
The AI in Clinical Trials Market has tremendous potential for improving patient recruitment processes by finding and screening prospective participants using predetermined inclusion and exclusion criteria. This skill promises to save time and money on patient recruiting, which is a common difficulty in clinical research. Wearable devices and other sensor technologies can continuously capture real-time physiological data from patients.
AI is increasingly used in both preclinical and clinical research. Advanced algorithms can quickly evaluate large databases of chemical compounds, determining which ones are most likely to attach to a target. This enables medication developers to explore the chemical landscape more effectively. Graphical representations and unique structural data show the leading region in the AI in Clinical Trials Market. The full examination of key drivers, prospects, and unique segmentation yields detailed and favorable results. The findings are validated using both primary and secondary research approaches, providing an overview of the AI in Clinical Trials Market.
Get an Exclusive Sample Copy of the Report at:https://www.maximizemarketresearch.com/request-sample/222597/
Regional Insights of the AI in Clinical Trials Market
North America, led by the United States, stands as a prominent hub for AI integration in clinical trials. This region benefits from a robust healthcare infrastructure, a well-established pharmaceutical industry, and significant investments in AI research. The FDA's supportive stance on AI's incorporation in clinical trials fosters innovation and adoption. Collaboration between pharmaceutical giants and tech companies further harnesses AI's potential for expediting drug development. European nations, including the UK, Germany, and France, are experiencing rapid AI adoption in the context of clinical trials. Renowned pharmaceutical companies, robust regulatory bodies, and government initiatives to promote AI in healthcare collectively drive market growth.
AI in Clinical Trials Market Segmentation
by Technology
Machine Learning
Natural Language processing
Deep Learning
Unspecified
by Application
Patient Recruitment
Data Analysis
Safety Monitoring
Drug Discovery
Personalized Medicine
Interested to Procure the Research Report? Inquire Before Buying :https://www.maximizemarketresearch.com/request-sample/222597/
AI in Clinical Trials Market Key Players:
1. Euretos
2. Biosymetric
3. Unlearn.AI,Inc.
4. Exscientia
5. IMB Corporation
6. AiCure
7. Antidote Technologies
8. Deep 6 AI
9. Innoplexus
10. IQVIA
Maximize Market Research is leading research firm, has also published the following reports:
About Maximize Market Research
Maximize Market Research provides B2B and B2C research on 6,500 high-growth emerging opportunities and technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics and communications, Internet of Things, Food and Beverages, Aerospace and defense, and other manufacturing sectors.